FLUCIDRIX Trademark

Trademark Overview


On Wednesday, June 6, 2001, a trademark application was filed for FLUCIDRIX with the United States Patent and Trademark Office. The USPTO has given the FLUCIDRIX trademark a serial number of 78067651. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, November 2, 2001. This trademark is owned by SmithKline Beecham Biologicals S.A.. The FLUCIDRIX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use; vaccines for human use

General Information


Serial Number78067651
Word MarkFLUCIDRIX
Filing DateWednesday, June 6, 2001
Status601 - ABANDONED - EXPRESS
Status DateFriday, November 2, 2001
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesvaccines for human use; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 12, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSmithKline Beecham Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, November 2, 2001ABANDONMENT - EXPRESS MAILED
Tuesday, September 25, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2001NON-FINAL ACTION MAILED
Tuesday, August 14, 2001ASSIGNED TO EXAMINER

Related Keywords


flucidrix human vaccines